Evidence map›Paper›PMID 15856317›Full record

ReviewPediatric nephrology (Berlin, Germany)2005

Familial hematurias: what we know and what we don't.

Clifford E Kashtan

Abstract readEditorialReview
PubMed Publisher
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The role of molecular genetics in diagnosing familial hematuria(s).Pediatric nephrology (Berlin, Germany) · 2012
    Review
  6. Article
  7. Article
  8. Familial hematuria.Pediatric nephrology (Berlin, Germany) · 2009
    Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Clifford E Kashtan
University of Minnesota Medical Center · US

Funding

GLOMERULAR PERMSELECTIVITY IN ALPORT SYNDROMER01DK057676 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI KASHTAN, CLIFFORD E · 2000 to 2004
$1.5M
NIDDK NIH HHS R01 DK57676
6 · The paper itself

Abstract

Over the past 30 years we have learned a great deal about the molecular genetics and natural history of familial forms of hematuria. Our enhanced understanding of these conditions has yet to generate effective therapies for Alport syndrome, the form of familial hematuria associated with end-stage renal disease. This review briefly presents the current state of knowledge about familial hematuria and argues for the organization of clinical therapeutic trials in Alport syndrome.

Indexed as

AnimalsCollagen Type IVDisease Models, AnimalFemaleHematuriaHumansImmunohistochemistryMaleNephritis, HereditaryCollagen Type IV

Identifiers

PMID15856317
OpenAlexW2023715117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.